Stock of Tempus AI, Inc. (TEM) is climbing about 9 percent on Wednesday morning trading after the company, along with Predicta Biosciences, announced the commercial expansion of a co-branded whole-genome sequencing assay, currently known as GenoPredicta.
The company's shares are currently trading at $54.30 on the Nasdaq, up 9.74 percent. The stock opened at $50.35 and has climbed as high as $54.91 so far in today's session. Over the past year, it has traded in a range of $39.01 to $104.32.
GenoPredicta intended for the comprehensive genomic characterization of hematologic malignancies and measurable residual disease monitoring.
For comments and feedback contact: editorial@rttnews.com
Business News
April 10, 2026 16:21 ET Inflation data from the U.S. was the main data event this week as the conflict in the Middle East continue. The minutes of the latest Fed policy session and the survey data on the services sector also made headlines. In Europe, manufacturing orders data from Germany was in focus. Price data from China drew attention in Asia.